ARL Bio Pharma provides analytical and microbiological testing for veterinary pharmacies. Our laboratory makes the test process simple so you can meet industry quality requirements and release safe, effective drug products easier and faster.
Submit Samples for testing through ARL's Client Portal.
This test measures the concentration of the active ingredient at a specific point in time.
- Potency Price List
- Benefits of Submitting Master Formulation Records
- Potency Test Failure Case Studies
- Drug Formulation and Its Impact on Analytical Testing
- Stability vs. Potency Testing
- Potency Testing Benefits and Requirements
- Importance of Sample Amounts and the Impact on Potency Testing
- Validated Potency Methods – NonGMP
ARL provides nonGMP and GMP testing. Click here to request a quote for GMP Potency testing.
A stability study measures the extent to which a product retains, within specified limits, and throughout its period of storage and use, the same properties and characteristics that it possessed at the time of compounding.
A study commonly includes: a stability indicating method assay, sterility (for sterile preparations), endotoxin (for most sterile preparations), pH, visual inspection, particulate matter, preservative effectiveness, preservative quantification, microbial limits (for non-sterile preparations), and the absence of specified organisms (for non-sterile preparations).
A sterility test detects microbial contamination. A satisfactory result indicates that no contaminating microorganism has been found in the sample examined under the conditions of the test.
A rapid sterility test detects microbial contamination. This validated alternative sterility test method per USP <1223> is effective and reliable for 503A and 503B Facilities. Rapid test provides objective results in as little as six days.
An endotoxin test detects toxins that are released from the cell wall of disrupted gram-negative bacteria.
An antimicrobial effectiveness test demonstrates the effectiveness of antimicrobial preservatives in preventing microbial proliferation in injections, topicals, oral products, single dose vials, and antacids packaged in multiple-dose containers.
These tests quantitate the total population of aerobic bacteria and yeast and molds in raw materials, in-process samples, finished products.
These tests verify the absence of objectionable microorganisms in drug products and raw materials.
A particulate matter tests for the presence of extraneous substances including: dust, glass, drug precipitates, rubber and other insoluble materials.